Back to search

Article

Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines

2022-10-18

Abstract excerpt

Advancements in cancer immunotherapy have shown significant outcomes in treating various types of cancers. In order to design effective immunotherapy, it is important to understand immune response of a patient based on its genomic profile. We compute prognostic biomarkers from 8346 cancer patients for twenty types of cancer. These prognostic biomarkers has been computed based on i) presence of 352 human leucocyte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d4097ff-c274-5de0-8d5d-05866ccfd825
DOI
10.1101/2022.10.15.512339
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokinesDOI 10.1101/2022.10.15.512339
Select a neighboring publication to make it the new centre.